Guilherme Ferreira Correia

Dr. Guilherme Ferreira Correia

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 September 2024 in Diseases
Verified
Journal Article
Open access
PDF file
GBGuilherme Bartolomeu-Gonçalves
Guilherme Bartolomeu-Gonçalves
Joyce Marinho de SouzaJoyce Marinho de Souza
Joyce Marinho de Souza
BFBruna Terci Fernandes
Bruna Terci Fernandes
LSLais Fernanda de Almeida Spoladori
Lais Fernanda de Almeida Spoladori
GCGuilherme Ferreira Correia
Guilherme Ferreira Correia
SYSueli Fumie Yamada-Ogatta
Sueli Fumie Yamada-Ogatta
Tuberculosis (TB) remains an impactful infectious disease, leading to millions of deaths every year. Mycobacterium tuberculosis causes the formation of granulomas, which will determine, through the host–pathogen relationship, if the infection will remain latent or evolve into active disease. Early TB diagnosis is life-saving, especially among immunocompromised individuals, and leads to proper treatment, preventing transmission. This review addresses different approaches to diagnosing TB, from traditional methods such as sputum smear microscopy to more advanced molecular techniques. Integrating these techniques, such as polymerase chain reaction (PCR) and loop-mediated isothermal amplification (LAMP), has significantly improved the sensitivity and specificity of M. tuberculosis identification. Additionally, exploring novel biomarkers and applying artificial intelligence in radiological imaging contribute to more accurate and rapid diagnosis. Furthermore, we discuss the challenges of existing diagnostic methods, including limitations in resource-limited settings and the emergence of drug-resistant strains. While the primary focus of this review is on TB diagnosis, we also briefly explore the challenges and strategies for diagnosing non-tuberculous mycobacteria (NTM). In conclusion, this review provides an overview of the current landscape of TB diagnostics, emphasizing the need for ongoing research and innovation. As the field evolves, it is crucial to ensure that these advancements are accessible and applicable in diverse healthcare settings to effectively combat tuberculosis worldwide.

29 March 2025 in Plants
Verified
Journal Article
Open access
PDF file
GCGuilherme Ferreira Correia
Guilherme Ferreira Correia
CACamila Antunes
Camila Antunes
CVCamila Cristina Valentim
Camila Cristina Valentim
LSLais Fernanda de Almeida Spoladori
Lais Fernanda de Almeida Spoladori
HSHelena Tiemi Suzukawa
Helena Tiemi Suzukawa
SYSueli Fumie Yamada-Ogatta
Sueli Fumie Yamada-Ogatta
Since ancient times, plants have been used in folk medicine to treat different diseases. Plants offer exceptional chemical diversity with a wide range of biological activities, and have therefore been the most promising sources for the discovery and development of drugs, including antimicrobial agents. This study reports the antibacterial effect of geraniol (GER), alone and in combination with biogenic silver nanoparticles (bioAgNPs), produced using the aqueous extract of Trichilia catigua bark, against planktonic and sessile cells of methicillin-resistant Staphylococcus aureus (MRSA), one of the main opportunistic and potentially fatal human pathogens. GER had a time-dependent bactericidal effect on planktonic cells, impairing the cell membrane integrity. In addition, GER inhibited the staphyloxanthin production, and molecular docking analyses supported the in silico affinity of GER to dehydrosqualene synthase (CrtM) and 4,4′-diaponeurosporen-aldehyde dehydrogenase (AldH), which are key enzymes within the pigment biosynthesis pathway in S. aureus. GER treatment increased the sensitivity of MRSA to hydrogen peroxide killing. GER displayed synergism with bioAgNPs against planktonic and sessile cells, inhibiting bacterial adhesion and the viability of biofilms formed on abiotic surfaces. MRSA planktonic and sessile cells treated with GER or GER/bioAgNPs displayed severe morphological and ultrastructural alterations. Notably, neither GER nor its combination caused in vitro and in vivo toxicity in mammalian cells and Galleria mellonella larvae, respectively. These findings suggest that the combination of GER/bioAgNPs may be a promising strategy to control MRSA infections.

14 August 2024 in Revista ft
Verified
Journal Article
Closed access
PBPaulo Borges
Paulo Borges
GSGislaine Silva-Rodrigues
Gislaine Silva-Rodrigues
BGBARBARA GREGIO
BARBARA GREGIO
GCGuilherme Ferreira Correia
Guilherme Ferreira Correia
JSJhuan Luiz Silva
Jhuan Luiz Silva
JSJoyce Marinho de Souza
Joyce Marinho de Souza
The infection by SARS-CoV-2, the virus responsible for COVID-19, triggers a series of immune responses in the host organism. These responses, while essential for pathogen elimination, can also cause significant damage to host tissues. This work details the mechanism of SARS-CoV-2 infection, from its structure to the processes of viral entry and replication, as well as the mechanisms related to infection and activation of the immune system, which can culminate in a cytokine storm. Understanding these mechanisms is crucial for developing effective therapeutic strategies, vaccines, and alternative therapies that were urgently released during the pandemic. Continuous research, especially related to the immune response, is necessary to enhance knowledge and preparedness for future pandemics.

2 June 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
GCGuilherme Ferreira Correia
Guilherme Ferreira Correia
BFBruna Terci Fernandes
Bruna Terci Fernandes
PBPaulo Borges
Paulo Borges
ICIsabela Madeira de Castro
Isabela Madeira de Castro
GBGuilherme Bartolomeu-Gonçalves
Guilherme Bartolomeu-Gonçalves
SYSueli Fumie Yamada-Ogatta
Sueli Fumie Yamada-Ogatta
Background/Objective: Leishmaniasis is a neglected tropical disease caused by species of the genus Leishmania, with a broad clinical spectrum that can overlap with other infectious and non-infectious conditions. Accurate species identification is critical for appropriate treatment and prognosis; however, parasitological methods are limited by suboptimal sensitivity, specificity, and inability to reliably differentiate species. This study aimed to develop and validate a real-time PCR assay based on melting-curve analysis (Leish-qPCR) for the detection of Leishmania spp. and the differentiation of Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis. Methods and Results: Genus-specific primers were designed based on the kDNA (kinetoplast DNA) minicircle consensus sequences of Leishmania species, while species-specific primers targeted the internal transcribed spacer 2 (ITS2) consensus regions of the ribosomal RNA locus of L. (L.) amazonensis and L. (V.) braziliensis. Analytical performance was evaluated in silico and in vitro using a panel of protozoa, fungi, and bacteria, exhibiting 100% specificity with no cross-amplification. The limit of detection was one copy per reaction for all targets using positive controls. Clinical validation was performed using skin biopsy specimens from patients with granulomatous lesions. The optimized Leish-qPCR assay, performed in separate reaction tubes within the same run, demonstrated reliable analytical specificity and sensitivity, with distinct and reproducible melting temperature (Tm) peaks across plasmid controls, parasite DNA, and clinical samples. Comparative analysis with histopathological examination demonstrated moderate agreement between the methods, supporting the applicability of the assay for sensitive detection and species-level discrimination of Leishmania spp. in clinical samples. Conclusions: The Leish-qPCR assay presented high sensitivity, specificity, and diagnostic accuracy, representing a promising tool for routine diagnosis of leishmaniasis and for the differentiation of L. (L.) amazonensis and L. (V.) braziliensis in clinical samples.